Streetbeat News

Products Services

KO

The FDA is reviewing concerns raised by Senate Majority Leader Chuck Schumer about the high caffeine content in Prime Energy, an energy drink founded by YouTube stars Logan Paul and KSI. Schumer claims the drink, which contains six times more caffeine than a standard can of Coca-Cola, is being marketed to children and teens. The company insists it complies with all FDA regulations and is not intended for anyone under 18. Canada's health agency has declared that Prime Energy should not be sold in the country due to its high caffeine content.

Portfolio Pulse from Vandana Singh

July 13, 2023 | 1:26 pm

HALO

RHHBY

Roche Holdings AG's Phase 3 OCARINA II trial evaluating Ocrevus as a twice-a-year 10-minute subcutaneous injection met its primary and secondary endpoints in patients with multiple sclerosis. The subcutaneous injection was shown to be non-inferior to Ocrevus given by intravenous infusion. The investigational subcutaneous formulation combines Ocrevus with Halozyme Therapeutics Inc's Enhanze drug delivery technology.

Portfolio Pulse from Vandana Singh

July 13, 2023 | 1:22 pm

INDA

MTEK

Maris-Tech Ltd. (NASDAQ:MTEK), a provider of AI-accelerated video solutions, has received a $392,000 order from a leading Indian company for electro-optical solutions. This marks Maris-Tech's entry into the Indian market. The order is based on Maris-Tech's Mars technology and is expected to be delivered in 2023.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 1:20 pm

CRKN

Crown Electrokinetics Corp. (NASDAQ:CRKN) has announced a revised revenue guidance for 2023 of $40 million with EBITDA of $15 million, once the capital needs of the fiber optics business are met. The company has recently reduced its debt and is focusing on growth opportunities in its fiber optics division. It also highlighted progress in its Smart Window Inserts production, with delivery expected in late summer.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 1:18 pm

CAMT

Camtek announced that it has received orders for 42 systems from several tier-1 semiconductor manufacturers. This has increased expectations for a stronger second half of 2023, leading to a rise in Camtek's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 1:16 pm

BYDDF

BYDDY

Chinese electric vehicle maker BYD Co Ltd, backed by Warren Buffett, has unveiled BYD World, a metaverse showroom developed with California-based metaverse company MeetKai. The platform allows potential buyers to interact virtually with the BYD brand and its products. Currently available in Ecuador and Chile, it will be expanded to all Latin American countries in a few weeks.

Portfolio Pulse from Anan Ashraf

July 13, 2023 | 1:11 pm

WRAP

Wrap Technologies' BolaWrap device has been successfully utilized by the Hillsborough County Sheriff's Office. The device, designed for non-lethal restraint of suspects, has been praised for its effectiveness.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 1:06 pm

CAMT

Camtek Ltd. (NASDAQ:CAMT) has announced receiving orders for 42 systems from several tier-1 semiconductor manufacturers. A significant portion of these orders are for the manufacture of chiplet modules and High Bandwidth Memory (HBM) for heterogeneous integration. The systems are expected to be delivered during the second half of 2023. The new orders highlight Camtek's strong position in the rapidly expanding market of heterogenous integration.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 1:06 pm

DOGEUSD

NVDA

TSLA

Elon Musk, CEO of Tesla and SpaceX, has launched a new venture, xAI, which aims to understand the universe's true nature. Dogecoin co-founder Billy Markus expressed enthusiasm for the project. Musk has reportedly secured thousands of processors from Nvidia Corp for his AI venture. Dogecoin was trading at $0.064 at the time of writing.

Portfolio Pulse from Mehab Qureshi

July 13, 2023 | 1:06 pm

SNPX

Synaptogenix, Inc. (NASDAQ:SNPX) announced that an abstract featuring secondary endpoint data of its Phase 2 Bryostatin-1 trial was accepted for presentation at the 11th International Brain Research Organization World Congress of Neuroscience. The trial data showed that Bryostatin-1 can prevent cognitive decline in advanced Alzheimer's disease patients. The company is also exploring strategic non-dilutive investment partners to facilitate continuing Bryostatin-1 development.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 1:05 pm